Mylan Pharmaceuticals is recalling one lot of Alprazolam tablets, used for the management of anxiety disorder, the short-term relief of symptoms of anxiety, and the treatment of panic disorder, with or without agoraphobia.
The product may be tainted with a foreign substance.
The firm has not received any reports adverse events to date.
The following product, packaged in bottles of 500 and distributed in the U.S. between July 2019, and August 2019, is being recalled:
NDC | Product Description and Strength | Size | Lot number | Expiry |
|---|---|---|---|---|
| 0378-4003-05 | Alprazolam Tablets, USP C-IV 0.5 mg | Bottles of 500 | 8082708 | September 2020 |
What to do
Mylan has notified customers by letter and is arranging for return of all recalled products.
Customers who purchased the product should quarantine and discontinue use of it, and contact Stericycle at (888) 843-0255 for the documentation packet to return product.
Consumers with questions may contact Mylan at (800) 796-9526 Monday through Friday from 8 a.m. – 5 p.m. (EST) or by email at customer.service@mylan.com (EST).
Keep an eye on your inbox, the lastest consumer news is on it's way!
Share your Comments